Printed From:

Lantus® Closely Mimics Physiologic Basal Insulin Secretion1

Lantus® has no pronounced peak

Conceptual depiction of endogenous insulin secretion and Lantus®

Lantus® is administered once a day and should be taken at the same time each day.2 The time course of action of insulins, including Lantus®, may vary between individuals and within the same individual.


References:

  1. Leahy JL. In: Leahy JL, Cefalu WT, eds. Insulin Therapy. New York, NY: Marcel Dekker; 2002:87-112.
  2. Lantus® Prescribing Information. February 2015.

Proven HbA1c control

See how Lantus® provides effective, improved glycemic control in diabetes patients.

Lantus® Prescribing Information. February 2015.

Once-daily dosing

Lantus® is a once-daily, long-acting insulin.**

**Lantus® Prescribing Information. February 2015.

Demonstrated long-term CV safety

Lantus® is a basal insulin with demonstrated long-term CV safety data††

††Including CV death, nonfatal MI, nonfatal stroke, revascularization, or hospitalization for heart failure. No difference was observed between Lantus® and standard of care in overall incidence of CV death, nonfatal MI, or nonfatal stroke. No difference was observed between treatment groups for death of any cause.